Abstract
Our recent work on the fabrication of microcapsules comprised of human serum albumin (HSA) and -α-dimyristoylphosphatitic acid (DMPA) by means of stepwise adsorption of HSA and DMPA on fluid droplet surfaces or charged colloids and subsequent dissolution of the cores is reviewed. The lipid self-assembles as a bilayer on the protein surface and the completed microcapsule serves as a biomimetic membrane model. The DMPA/HSA microcapsules have good biocompatibility and the potential for the insertion of recognition units in the lipid bilayers. The structure and properties of the lipid/protein microcapsules are described and their potential for applications in sustained drug release are introduced.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
